ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2026 Earnings Call Transcript May 6, 2026
ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.04.
Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to ACADIA Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to turn the...
